“Where do I start?”: Strategies for selecting the first dose for human clinical trials White Paper “どこから始めればいいの?”: ヒト臨床試験で最初の投与量を選定するための戦略 This guide to dose selection for first-in-human studies explains the conceptual framework, methods, and tools…Certara2020年12月22日
Clinical Pharmacology Gap Analysis: Lessons Learned Blog 臨床薬理学におけるギャップ分析:得られた教訓 Clinical pharmacology gap analysis is a tool for outlining your drug program’s needs, prioritizing these…Certara2018年8月10日
Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy Publication Metformin Treatment of Type 2 Diabetes Mellitus in Pregnancy: Update on Safety and Efficacy Certara2018年4月25日
Using M&S to Evaluate Oncology Drug Dosing Blog Using M&S to Evaluate Oncology Drug Dosing There are numerous challenges in developing oncology drugs: (1) they are often very toxic which…Certara2018年4月13日
Using a Pharmacology to Payer Framework to Support Product Development Blog Using a Pharmacology to Payer Framework to Support Product Development Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…Certara2018年3月16日
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Certara2018年3月1日
Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Blog グローバル承認申請のモデリング&シミュレーション (M&S)のための地籍調査 Analogous to how a geologist surveys the “lay of the land” to determine if oil…Certara2018年2月16日
Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Publication Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Certara2017年9月15日
Drug Asset Evaluation: Increasing “Probability of Success” of a Deal White Paper Drug Asset Evaluation: Increasing “Probability of Success” of a Deal Certara’s due diligence/asset evaluation teams are comprised of drug development and commercialization experts who advise…Certara2017年8月24日
Investigational Drug Gap Analysis Brochure Investigational Drug Gap Analysis As the process of drug development has increased in cost and complexity, Certara has developed…Certara2017年8月14日